Physician profile
Scott B Branting
NPI 1861457517
$209.70
in general payments reported to CMS, 2019-2025
9 companies · $81.30 in 2025
The $81.30 reported for 2025 was less than what a typical Pain Medicine (Anesthesiology) provider received nationally (typical 2025 total: $458).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $14.36 · 2020: $30.08 · 2021: $16.97 · 2022: $19.03 · 2024: $47.96 · 2025: $81.30.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $129.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $129.26 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $63.87 | 2024-2025 | Retia Medical, Bis |
| Abbott Laboratories | $29.17 | 2024 | Thoratec Heartmate 3 Lvas Implant Kit |
| La Jolla Pharmaceutical Company | $20.60 | 2025 | Giapreza |
| Pacira Pharmaceuticals Incorporated | $19.03 | 2022 | |
| Merck Sharp & Dohme LLC | $16.97 | 2021 | |
| Fisher & Paykel Healthcare INC | $15.62 | 2025 | Fisher & Paykel Healthcare |
| Mallinckrodt Hospital Products INC. | $15.55 | 2020 | |
| Vyaire Medical, INC. | $14.53 | 2020 | |
| Mallinckrodt Enterprises LLC | $14.36 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Scott Branting listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.